Trivariance Innovations: A partner for developing and executing critical path towards commercialization
Truly disruptive innovations are the foundation of what makes the scientific process so powerful. However, the commercial development and practical realization of such innovations are often far more challenging, especially for individuals or institutions that focus primarily on developing these innovations. The current landscape often requires innovators to seek seed funding on their own from funding sources that offer little business development guidance. This results in one of two outcomes 1. They receive often infrequent and ill-informed advising from investors or 2. They seek advising from another source e.g. university center or consultant. It is obvious that the former presents many challenges to the innovator and less likely a positive outcome, however, the latter case also results in challenges often unanticipated by the innovator. For example, the innovator being pulled between strategic plans provided from both advising groups. This is inefficient and introduces risks, at best. In order to maximize positive outcomes and efficiently commercialize disruptive innovations, innovators require a commercialization partner that offers seed funding investments as well as integrated, hands-on business development. Trivariance is the answer.
Trivariance Innovations has identified this unmet need and offers a process of commercialization integrated within our Angel Fund. Trivariance is the first internationally active angel fund, structured and operating between USA and Europe. Trivariance was founded by seasoned executives, think-tank renowned scientists and engineers to create an environment for the proliferation of new disruptive technologies and services solutions to the business community worldwide. The key to our success is our proven integrated startup process that streamlines and ensures continuity through start-up and projects lifecycles, maximizing results and lowering risks. 1. Innovation – the disruptive and brilliant technological advances made by talented engineers and scientists. 2. Collaboration – leveraging our team with 30+ years of business development experience and a diverse think tank team to find best applications of each technology. 3. Angel Fund – $3M in seed investments for execution of the critical path to commercialization. 4. Asset Farming – the use of our integrated management and strategic planning team maximizes potentials for a successful exit. There are five focus areas in which we are currently building our portfolio:
- Energy
- Life Sciences – Health Care
- Financial
- Manufacturing
- Aerospace
We are proud to announce that Trivariance is actively seeking partners with innovations addressing one or more of our five focus areas. We have partnered with innovators at several universities across the US and Europe and with our expanding network of collaborators and partners (including the New Jersey Innovation Institute, and the National Center for Manufacturing Sciences) Trivariance will provide the best chance of commercial success for our innovative partners. We look forward to working with you in the future.
